Targeted Biotech Potential clients operate in biotechnology research and require high-quality GPCR, kinase assays and primary cell-based screening. Multispan can position as a provider of endogenously expressed targets and stable cell lines to accelerate assay development, HTS and SAR workflows for drug discovery.

Induced Partnerships Current collaborations with leading pharma and biotech firms indicate a proven track record. Use existing success to approach similar mid-to-large biotechs and biopharma players seeking reliable assay readiness and faster IND timelines.

Cost-Effective Capacity With revenue in the low single digits and a lean team, emphasize scalable, cost-efficient screening solutions and flexible engagement models that fit smaller budgets and pilot projects, while offering high-quality outputs.

Therapeutic Focus Target cardiovascular, metabolic, CNS, inflammation, immunology and oncology indication areas where Multispan already demonstrates capabilities. Align outreach with pharma programs in these therapeutic areas seeking phenotypic and signaling assays.

Global Access Highlight the ability to support international collaborations and diverse sponsor needs by delivering stable cell line banks and assay platforms that enable cross-border research, regulatory readiness, and rapid technology transfer.